The Valgen Medtech DragonFly™ System Receives EU Approval for FMR Indication
To date, DragonFly™ has received regulatory approvals in 15 countries and regions, with routine clinical use and commercial adoption already underway in key international markets including Latin America and Southeast Asia
June 24, 2026